Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma

Published:2012-07 Issue:7 Volume:44 Page:610-616
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Decaens Thomas,Luciani Alain,Itti Emmanuel,Hulin Anne,Roudot-Thoraval Françoise,Laurent Alexis,Zafrani Elie Serge,Mallat Ariane,Duvoux Christophe

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference52 articles.

1. Novel advancements in the management of hepatocellular carcinoma in 2008;Llovet;J Hepatol,2008

2. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum;Burroughs;Lancet Oncol,2004

3. The applicability of mTOR inhibition in solid tumors;Konings;Curr Cancer Drug Targets,2009

4. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor;Guba;Nat Med,2002

5. Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma;Semela;J Hepatol,2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights in Molecular Therapies for Hepatocellular Carcinoma;Cancers;2024-05-10

2. mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma;International Journal of Biological Sciences;2024

3. Autophagy: A challengeable paradox in cancer treatment;Cancer Medicine;2023-02-09

4. Capillarisenol C, a novel bisphenol from Artemisia capillaris, induces autophagic death in hepatocellular carcinoma through endoplasmic reticulum stress;2022-09-15

5. PROX1, a Key Mediator of the Anti-Proliferative Effect of Rapamycin on Hepatocellular Carcinoma Cells;Cells;2022-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3